Primary care services and emergency department visits in blended fee-for-service and blended capitation models: evidence from Ontario, Canada
ConclusionPrimary care physicians practicing in Ontario ’s blended capitation model provide fewer primary care services compared to those practicing in a blended FFS model. Although the overall rate of ED visits was higher among patients enrolled to FHO physicians, multimorbid patients of FHO physicians make fewer urgent and very-urgent ED visits. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - May 8, 2023 Category: Health Management Source Type: research

Education and medication use later in life and the role of intelligence
AbstractWe investigate the association between education and disease-specific medications in old age, prescribed by medical doctors, accounting for confounders and how this association is shaped by intelligence. We use administrative data on men including prescribed medication records. To account for endogeneity of education we estimate a structural model, consisting of (i) an ordered probit for educational attainment, (ii) a Gompertz mortality model for survival up to old age, (iii) a probit model for prescribed medications in old age, (iv) a measurement system using IQ tests to identify latent intelligence. The results s...
Source: The European Journal of Health Economics - May 2, 2023 Category: Health Management Source Type: research

Generating EQ-5D-3L health utility scores from the Edinburgh Postnatal Depression Scale: a perinatal mapping study
ConclusionsThis direct mapping algorithm allows the estimation of health utility values from EPDS scores. The algorithm has good external validity but is likely to perform better in samples with higher health status. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - April 24, 2023 Category: Health Management Source Type: research

Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin ’s lymphoma
ConclusionAdding rituximab to LMB chemotherapy in children and adolescents with high-risk mature B-cell non-Hodgkin's lymphoma is highly cost-effective in France.Trial registrationClinicalTrials.gov identifier: NCT01516580. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - April 14, 2023 Category: Health Management Source Type: research

Referring physicians' intention to use hospital report cards for hospital referral purposes in the presence or absence of patient-reported outcomes: a randomized trial
ConclusionsThis study underpins the purpose of HRCs, namely to support referring physicians in searching for a hospital. Nevertheless, only a minority would support the use of HRCs for the next hospital search in its current form. We showed that presenting relevant information on HRCs did not increase their use intention. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - April 13, 2023 Category: Health Management Source Type: research

Health impact of borders: general reflections and a case study from the Polish –German border
ConclusionStrong effort should be invested to overcome political and cultural borders to improve the health of the population in border regions. Similarly, increased cross-border acute healthcare must be seen in the context of rural health and the special situation of small rural hospitals in rural peripheral areas. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - April 12, 2023 Category: Health Management Source Type: research

Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Syst ème National des Données de Santé (SNDS) database: a retrospective cohort study
ConclusionsThis study showed a high economic burden of MM in France ( €72.37 K/patient/year in the first year) and the diversity of regimens used in late-line treatments. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - April 1, 2023 Category: Health Management Source Type: research

Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort
This study aims to describe and assess the effect of comorbidities on healthcare expenditures (direct medical cost and non-medical costs including transport ation and compensatory allowances) for patients with ESKD in France while considering the modality and duration of renal replacement therapy (RRT). This study included adults who started RRT for the first time between 2012 and 2014 in France and were followed for 5 years. Generalized linear models were built to predict mean monthly cost (MMC) by integrating first the time duration in the cohort, then patient characteristics and finally the duration of use of each trea...
Source: The European Journal of Health Economics - April 1, 2023 Category: Health Management Source Type: research